Did you know that Canadian feet were actually the first to touch down on the Moon during the Apollo 11 mission?

More than 30 people got sick in a gastrointestinal illness outbreak on a Viking cruise. Among 355 guests on its Viking Polaris ship, 28 reported being ill during its current voyage, along with ...

Viking Therapeutics' VK2735, a GLP-1 candidate, has driven significant share price gains but faces stiff competition from Eli Lilly and Novo Nordisk. Viking's Q1 earnings show no revenue ...

including another on the Viking Mars ship in January. Most were caused by norovirus. The illness is often associated with cruise ships, but they account for only 1% of all reported outbreaks. Dr. Dean ...

Jay Olson; Analyst; Oppenheimer & Co., Inc. Welcome to the Viking Therapeutics' first-quarter 2025 financial results conference call. (Operator Instructions) As a reminder, this conference call is ...

With recent cuts to Mars Sample Return, China will lead the charge to Mars and to the moon. Credit: NASA In the Senate hearing considering the confirmation of Jared Isaacman as NASA Administrator ...

Don’t get stuck with an unsafe boat needing costly repairs. Insure your 1972 Viking Boat SPORT DECK V-219S for just $100/year*. More freedom: You’re covered on all lakes, rivers and oceans within 75 ...

NASA's Mars Reconnaissance Orbiter (MRO ... drives starting on Feb. 2 as Curiosity trucked along at a top speed of 0.1 mph (0.16 kph) from Gediz Vallis channel on the journey to its next science ...

Viking Therapeutics is one of the few biotech stocks that has shown immense potential in the obesity space. It is developing VK2735, an investigational novel dual GLP-1 and GIP receptor agonist ...